Response Genetics makes McNulty chief operating officer
This article was originally published in Clinica
Executive Summary
Michael McNulty is to become chief operating officer of molecular diagnostics firm Response Genetics. From 12 July, Mr McNulty will be responsible for the firm’s strategy and corporate development. Before joining Los Angeles, California-based Response, Mr McNulty worked as general manager, diagnostics at Agilent Technologies. He has also held the role of vice-president, laboratory operations at Berkeley HeartLab, which now known as Celera Diagnostics. Response Genetics is focused on the development of PCR-based tests for detecting non-small cell lung, colorectal and gastric cancers.